Literature DB >> 7911765

ICAM-1 and integrin expression on isolated human alveolar type II pneumocytes.

J Guzman1, T Izumi, S Nagai, U Costabel.   

Abstract

Adhesion molecules are involved in the recruitment of leucocytes to sites of inflammation. In this study, we determined the expression of several adhesion molecules on isolated human alveolar type II pneumonocytes. Type II pneumocytes were isolated from 10 normal lung specimens, by enzymatic digestion with dispase, followed by metrizamide gradient centrifugation and panning on immunoglobulin G (IgG)-coated plastic dishes. With the freshly isolated type II cells, immunostaining was performed using a sensitive immunoperoxidase slide technique. In all cases, 60-90% of type II cells were positive for intercellular adhesion molecule-1 (ICAM-1) (CD54). A minor portion of type II cells expressed the alpha 4 (CD49d) subunit of the beta 1-integrins, and the alpha-v (CD51) subunit of the vitronectin receptor. CD11a, CD11b, CD11c, CD18, CD49b, and CD49f failed to demonstrate any immunostaining with type II cells. In conclusion, the observation of the expression of ICAM-1 and, to a lesser degree, of some integrin subunits, may indicate that alveolar type II cells participate in local immune and inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7911765     DOI: 10.1183/09031936.94.07040736

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  9 in total

1.  Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma.

Authors:  G Akiri; M M Cherian; S Vijayakumar; G Liu; A Bafico; S A Aaronson
Journal:  Oncogene       Date:  2009-04-20       Impact factor: 9.867

2.  Associations among lung function, arterial elasticity, and circulating endothelial and inflammation markers: the multiethnic study of atherosclerosis.

Authors:  Daniel A Duprez; Mary O Hearst; Pamela L Lutsey; David M Herrington; Pamela Ouyang; R Graham Barr; David A Bluemke; David McAllister; J Jeffrey Carr; David R Jacobs
Journal:  Hypertension       Date:  2013-01-02       Impact factor: 10.190

3.  Adhesion molecules involved in hepoxilin A3-mediated neutrophil transepithelial migration.

Authors:  B P Hurley; A Sin; B A McCormick
Journal:  Clin Exp Immunol       Date:  2007-11-15       Impact factor: 4.330

4.  Association of circulating adhesion molecules with lung function. The CARDIA study.

Authors:  Bharat Thyagarajan; Lewis J Smith; R Graham Barr; Myron D Gross; Akshay Sood; Ravi Kalhan; David R Jacobs
Journal:  Chest       Date:  2009-02-18       Impact factor: 9.410

5.  Regulation and function of adhesion molecule expression by human alveolar epithelial cells.

Authors:  A C Cunningham; J A Kirby
Journal:  Immunology       Date:  1995-10       Impact factor: 7.397

6.  CD208/dendritic cell-lysosomal associated membrane protein is a marker of normal and transformed type II pneumocytes.

Authors:  Bruno Salaun; Blandine de Saint-Vis; Nathalie Pacheco; Yves Pacheco; Arnaud Riesler; Sylvie Isaac; Caroline Leroux; Valérie Clair-Moninot; Jean-Jacques Pin; Janice Griffith; Isabelle Treilleux; Sophie Goddard; Jean Davoust; Monique Kleijmeer; Serge Lebecque
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

7.  Imbalance of pro- and anti-inflammatory cytokines in pulmonary sarcoidosis.

Authors:  J Müller-Quernheim
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

8.  Epithelium-Specific Ets-Like Transcription Factor 1, ESE-1, Regulates ICAM-1 Expression in Cultured Lung Epithelial Cell Lines.

Authors:  Zhiqi Yu; Jun Xu; Jinbao Liu; Jing Wu; Chan Mi Lee; Li Yu; Jim Hu
Journal:  Mediators Inflamm       Date:  2015-06-21       Impact factor: 4.711

9.  Serum levels of IL-8 and ICAM-1 as biomarkers for progressive massive fibrosis in coal workers' pneumoconiosis.

Authors:  Jong Seong Lee; Jae Hoon Shin; Byung-Soon Choi
Journal:  J Korean Med Sci       Date:  2015-01-21       Impact factor: 2.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.